According to Cerus's latest financial reports and stock price the company's current number of shares outstanding is 180,938,000. At the end of 2023 the company had 180,938,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.18 B | 1.95% |
2022 | 0.17 B | 2.53% |
2021 | 0.17 B | 3.42% |
2020 | 0.16 B | 17.08% |
2019 | 0.14 B | 5.11% |
2018 | 0.13 B | 18.95% |
2017 | 0.11 B | 10.51% |
2016 | 0.10 B | 5.36% |
2015 | 98.2 M | 24.62% |
2014 | 78.8 M | 11.18% |
2013 | 70.88 M | 27.34% |
2012 | 55.66 M | 16.67% |
2011 | 47.71 M | 21.37% |
2010 | 39.31 M | 12.31% |
2009 | 35 M | 7.59% |
2008 | 32.53 M | 2.14% |
2007 | 31.85 M | 14.57% |
2006 | 27.8 M | 24.26% |
2005 | 22.37 M | 0.93% |
2004 | 22.16 M | 0.61% |
2003 | 22.03 M | 38.79% |
2002 | 15.87 M | 1.04% |
2001 | 15.71 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Boston Scientific BSX | 1,464,500,000 | 709.39% | ๐บ๐ธ USA |
Utah Medical Products UTMD | 3,630,000 | -97.99% | ๐บ๐ธ USA |
Haemonetics HAE | 50,768,000 | -71.94% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | 5,410,000 | -97.01% | ๐บ๐ธ USA |